Literature DB >> 31539054

Limited reproducibility of MUCH and WUCH: evidence from the ELSA study.

Giuseppe Mancia1,2, Rita Facchetti3, Cesare Cuspidi3, Michele Bombelli3, Giovanni Corrao4, Guido Grassi3.   

Abstract

AIMS: To evaluate the long-term reproducibility of masked (MUCH) and white-coat uncontrolled hypertension (WUCH), an information crucial for determining the long-term prognostic impact of these conditions. METHODS AND
RESULTS: Reproducibility of MUCH and WUCH was assessed in 1664 hypertensive patients recruited for the European Lacidipine Study on Atherosclerosis and treated with atenolol or lacidipine (±additional drugs) during a 4-year period. Office and 24 h blood pressure (BP) was measured at baseline and every year during treatment, allowing repeated classification of either condition. After 1 year of treatment 21.1% and 17.8% of the patients were classified as MUCH and WUCH, respectively. For both conditions the prevalence was similar in the following years, although with a large change in patients composition because only about 1/3 of patients classified as MUCH or WUCH at one set of office and ambulatory BP measurements maintained the same classification at a subsequent set of measurements. In only 4.5% and 6.2% MUCH and WUCH persisted throughout the treatment period. MUCH and WUCH reproducibility was worse than that of patients showing control or lack of control of both office and ambulatory BP, i.e. controlled and uncontrolled hypertension, respectively.
CONCLUSION: Both MUCH and WUCH display poor reproducibility over time. This should be taken into account in studies assessing the long-term prognostic value of these conditions based on only one set of BP measurements. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Antihypertensive treatment; Blood pressure; Masked uncontrolled hypertension; White-coat uncontrolled hypertension

Mesh:

Substances:

Year:  2020        PMID: 31539054     DOI: 10.1093/eurheartj/ehz651

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

Review 1.  Update on Treatment of Hypertension After Renal Transplantation.

Authors:  Christos Chatzikyrkou; Roland E Schmieder; Mario Schiffer
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

2.  White coat hypertension: European versus American guidelines-A new dilemma.

Authors:  Cesare Cuspidi; Federico Paoletti; Marijana Tadic
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-08       Impact factor: 3.738

3.  Left ventricular hypertrophy in isolated and dual masked hypertension.

Authors:  Cesare Cuspidi; Rita Facchetti; Fosca Quarti-Trevano; Raffaella Dell'Oro; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

4.  A prospective cohort study of home blood pressure monitoring based on an intelligent cloud platform (the HBPM-iCloud study): rationale and design.

Authors:  Hailan Zhu; Xiaoyan Liang; Xiong-Fei Pan; Chunyi Huang; Jian Kuang; Weibiao Lv; Qingchun Zeng; Weiyi Mai; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2020-06-10       Impact factor: 5.091

5.  American Versus European Hypertension Guidelines: The Case of White Coat Hypertension.

Authors:  Cesare Cuspidi; Federico Paoletti; Marijana Tadic; Carla Sala; Raffaella Dell'Oro; Guido Grassi; Giuseppe Mancia
Journal:  Am J Hypertens       Date:  2020-07-18       Impact factor: 2.689

Review 6.  The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management.

Authors:  Francesco P Cappuccio
Journal:  Eur Cardiol       Date:  2020-08-24

Review 7.  Blood pressure and its variability: classic and novel measurement techniques.

Authors:  Aletta E Schutte; Anastasios Kollias; George S Stergiou
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 49.421

8.  White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study.

Authors:  Qin Wang; Yu Wang; Jinwei Wang; Luxia Zhang; Ming-Hui Zhao
Journal:  J Transl Med       Date:  2020-06-15       Impact factor: 5.531

Review 9.  Arterial hypertension - Clinical trials update 2021.

Authors:  Hussam Al Ghorani; Felix Götzinger; Michael Böhm; Felix Mahfoud
Journal:  Nutr Metab Cardiovasc Dis       Date:  2021-09-16       Impact factor: 4.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.